Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck

Detalles Bibliográficos
Autores principales: Leus, A.J.G., Horváth, B., Terra, J.B., Diercks, G.F.H., Plaat, B.E.C., Oosting, S.F., Rácz, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298061/
https://www.ncbi.nlm.nih.gov/pubmed/34597438
http://dx.doi.org/10.1111/bjd.20774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298061/
https://www.ncbi.nlm.nih.gov/pubmed/34597438
http://dx.doi.org/10.1111/bjd.20774

Ejemplares similares